Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma (NAMSW) Debt Ratio (2022 - 2025)

Historic Debt Ratio for NewAmsterdam Pharma (NAMSW) over the last 4 years, with Q3 2025 value amounting to 0.06.

  • NewAmsterdam Pharma's Debt Ratio rose 3107.25% to 0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06, marking a year-over-year increase of 3107.25%. This contributed to the annual value of 0.04 for FY2024, which is 1976.93% up from last year.
  • Per NewAmsterdam Pharma's latest filing, its Debt Ratio stood at 0.06 for Q3 2025, which was up 3107.25% from 0.03 recorded in Q2 2025.
  • Over the past 5 years, NewAmsterdam Pharma's Debt Ratio peaked at 0.07 during Q1 2024, and registered a low of 0.0 during Q2 2023.
  • Over the past 4 years, NewAmsterdam Pharma's median Debt Ratio value was 0.04 (recorded in 2023), while the average stood at 0.04.
  • Per our database at Business Quant, NewAmsterdam Pharma's Debt Ratio surged by 32126073.57% in 2024 and then plummeted by 5753.45% in 2025.
  • NewAmsterdam Pharma's Debt Ratio (Quarter) stood at 0.01 in 2022, then soared by 395.3% to 0.04 in 2023, then increased by 19.77% to 0.04 in 2024, then surged by 30.01% to 0.06 in 2025.
  • Its Debt Ratio stands at 0.06 for Q3 2025, versus 0.03 for Q2 2025 and 0.03 for Q1 2025.